Stimulation with type I collagen induces changes in gene expression in peripheral blood mononuclear cells from patients with diffuse cutaneous systemic sclerosis (scleroderma)

Clinical and Experimental Immunology

Volumn 161, Issue 3, 2010, Pages 426-435

  Atamas, S P ^a   Luzina, I G ^a   Ingels, J ^b   Choi, J ^a   Wong, W K ^c   Furst, D E ^d   Clements, P J ^d   Postlethwaite, A E ^b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^c School of Public Health   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Autoimmunity; Collagen; Gene expression; Inflammation; Scleroderma

Indexed keywords

AUTOANTIGEN; COLLAGEN TYPE 1;

ADULT; AGED; ANTIGENICITY; ARTICLE; CELL CULTURE; CONTROLLED STUDY; CULTURE MEDIUM; FEMALE; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SCLERODERMA;

AGED; CELLS, CULTURED; CLUSTER ANALYSIS; COLLAGEN TYPE I; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SCLERODERMA, DIFFUSE;

EID: 77955720672     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2010.04189.x     Document Type: Article

References (34)

1. Postlethwaite AE. Role of T cells and cytokines in effecting fibrosis. Int Rev Immunol 1995 12 : 247 258.
2. Postlethwaite AE. Bidirectional interactions between T cells and the extracellular matrix. Transpl Immunol 1997 5 : 289 291.
3. Luzina IG, Todd NW, Iacono AT, Atamas SP. Roles of T lymphocytes in pulmonary fibrosis. J Leukoc Biol 2008 83 : 237 244.
4. Atamas SP, White B. The role of chemokines in the pathogenesis of scleroderma. Curr Opin Rheumatol 2003 15 : 772 777.
5. Atamas SP, White B. Cytokine regulation of pulmonary fibrosis in scleroderma. Cytokine Growth Factor Rev 2003 14 : 537 550.
6. Manetti M, Neumann E, Muller A et al. Endothelial/lymphocyte activation leads to prominent CD4+ T cell infiltration in the gastric mucosa of patients with systemic sclerosis. Arthritis Rheum 2008 58 : 2866 2873.
7. Xie Y, Zhang X, Wakasugi S, Makino T, Inoue Y, Ihn H. Immunohistochemical characterization of the cellular infiltrate in localized scleroderma. Int J Dermatol 2008 47 : 438 442.
8. Hebbar M, Gillot JM, Hachulla E et al. Early expression of E-selectin, tumor necrosis factor alpha, and mast cell infiltration in the salivary glands of patients with systemic sclerosis. Arthritis Rheum 1996 39 : 1161 1165.
9. Kraling BM, Maul GG, Jimenez SA. Mononuclear cellular infiltrates in clinically involved skin from patients with systemic sclerosis of recent onset predominantly consist of monocytes/macrophages. Pathobiology 1995 63 : 48 56.
10. Wells AU, Lorimer S, Majumdar S et al. Fibrosing alveolitis in systemic sclerosis: increase in memory T-cells in lung interstitium. Eur Respir J 1995 8 : 266 271.
11. Luzina IG, Todd NW, Nacu N et al. Regulation of pulmonary inflammation and fibrosis through expression of integrins alphaVbeta3 and alphaVbeta5 on pulmonary T lymphocytes. Arthritis Rheum 2009 60 : 1530 1539.
12. Luzina IG, Atamas SP, Wise R et al. Occurrence of an activated, profibrotic pattern of gene expression in lung CD8+ T cells from scleroderma patients. Arthritis Rheum 2003 48 : 2262 2274.
13. Luzina IG, Atamas SP, Wise R, Wigley FM, Xiao HQ, White B. Gene expression in bronchoalveolar lavage cells from scleroderma patients. Am J Respir Cell Mol Biol 2002 26 : 549 557.
14. Atamas SP, Yurovsky VV, Wise R et al. Production of type 2 cytokines by CD8+ lung cells is associated with greater decline in pulmonary function in patients with systemic sclerosis. Arthritis Rheum 1999 42 : 1168 1178.
15. Sakkas LI, Xu B, Artlett CM, Lu S, Jimenez SA, Platsoucas CD. Oligoclonal T cell expansion in the skin of patients with systemic sclerosis. J Immunol 2002 168 : 3649 3659.
16. Stuart JM, Postlethwaite AE, Kang AH. Evidence for cell-mediated immunity to collagen in progressive systemic sclerosis. J Lab Clin Med 1976 88 : 601 607.
17. McKown KM, Carbone LD, Bustillo J, Seyer JM, Kang AH, Postlethwaite AE. Induction of immune tolerance to human type I collagen in patients with systemic sclerosis by oral administration of bovine type I collagen. Arthritis Rheum 2000 43 : 1054 1061.
18. Kravis TC, Ahmed A, Brown TE, Fulmer JD, Crystal RG. Pathogenic mechanisms in pulmonary fibrosis: collagen-induced migration inhibition factor production and cytotoxicity mediated by lymphocytes. J Clin Invest 1976 58 : 1223 1232.
19. Schrier DJ, Phan SH, Ward PA. Cellular sensitivity to collagen in bleomycin-treated rats. J Immunol 1982 129 : 2156 2159.
20. Warrington KJ, Nair U, Carbone LD, Kang AH, Postlethwaite AE. Characterisation of the immune response to type I collagen in scleroderma. Arthritis Res Ther 2006 8 : R136.
21. Duan H, Fleming J, Pritchard DK et al. Combined analysis of monocyte and lymphocyte messenger RNA expression with serum protein profiles in patients with scleroderma. Arthritis Rheum 2008 58 : 1465 1474.
22. Tan FK, Zhou X, Mayes MD et al. Signatures of differentially regulated interferon gene expression and vasculotrophism in the peripheral blood cells of systemic sclerosis patients. Rheumatology (Oxf) 2006 45 : 694 702.
23. Postlethwaite AE, Wong WK, Clements P et al. A multicenter, randomized, double-blind, placebo-controlled trial of oral type I collagen treatment in patients with diffuse cutaneous systemic sclerosis. I. Oral type I collagen does not improve skin in all patients but may improve skin in late-phase disease. Arthritis Rheum 2008 58 : 1810 1822.
24. Kang AH, Piez KA, Gross J. Characterization of the alpha-chains of chick skin collagen and the nature of the NH2-terminal cross-link region. Biochemistry 1969 8 : 3648 3655.
25. Kang AH, Seyer JM. Compilation of collagen data. In : Fasma GD, ed. Handbook of biochemistry. Cleveland, OH : CRC Press, 1996 : 474 489.
26. Rus V, Atamas SP, Shustova V et al. Expression of cytokine- and chemokine-related genes in peripheral blood mononuclear cells from lupus patients by cDNA array. Clin Immunol 2002 102 : 283 290.
27. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Statist Soc B 1995 57 : 289 300.
28. Sato S, Fujimoto M, Hasegawa M et al. Serum soluble CTLA-4 levels are increased in diffuse cutaneous systemic sclerosis. Rheumatology (Oxf) 2004 43 : 1261 1266.
29. van Lieshout AW, Vonk MC, Bredie SJ et al. Enhanced interleukin-10 production by dendritic cells upon stimulation with Toll-like receptor 4 agonists in systemic sclerosis that is possibly implicated in CCL18 secretion. Scand J Rheumatol 2009 38 : 282 290.
30. Fineschi S, Goffin L, Rezzonico R et al. Antifibroblast antibodies in systemic sclerosis induce fibroblasts to produce profibrotic chemokines, with partial exploitation of Toll-like receptor 4. Arthritis Rheum 2008 58 : 3913 3923.
31. Lafyatis R, York M. Innate immunity and inflammation in systemic sclerosis. Curr Opin Rheumatol 2009 21 : 617 622.
32. Vogel WF. Collagen-receptor signaling in health and disease. Eur J Dermatol 2001 11 : 506 514.
33. Leitinger B, Hohenester E. Mammalian collagen receptors. Matrix Biol 2007 26 : 146 155.
34. Postlethwaite AE, Wong WK, Ingels J, Kang AH, Clements P, Furst D. Maximal T cell reactivity to type I collagen (CI) is present during the first 3 years of diffuse systemic sclerosis (SSc). Arthritis Rheum 2005 52 : S462 (Abstract).